These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6343980)

  • 41. Antibiotic susceptibility of nonpigmented Serratia marcescens.
    Thornton GF; Cramer JA
    Antimicrob Agents Chemother (Bethesda); 1970; 10():514-6. PubMed ID: 4939745
    [No Abstract]   [Full Text] [Related]  

  • 42. [Effect of subinhibitory levels of aminoglycosides and fluoroquinolines on hydrophobicity and motility of Serratia marcescens].
    Majtán V; Majtánová L
    Epidemiol Mikrobiol Imunol; 2001 Feb; 50(1):26-30. PubMed ID: 11233670
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A laboratory assessment of the activities of four aminoglycosides.
    Schrire L; Robinson RG; Koornhof HJ
    S Afr Med J; 1984 Jun; 65(23):922-4. PubMed ID: 6427946
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Study on pathogenicity, drug sensitivity and pigment production of Serratia marcescens.
    Wu KH
    Taiwan Yi Xue Hui Za Zhi; 1976 Feb; 75(2):120-9. PubMed ID: 787472
    [No Abstract]   [Full Text] [Related]  

  • 45. Analysis of R factors in Serratia marcescens strains isolated from the "Hospital Universitario de Caracas".
    Rodríguez Lemoine V; de Ramírez Y; Pedroza R
    Acta Cient Venez; 1983; 34(3-4):228-32. PubMed ID: 6399968
    [No Abstract]   [Full Text] [Related]  

  • 46. Site-directed mutagenesis studies to probe the role of specific residues in the external loop (L3) of OmpF and OmpC porins in susceptibility of Serratia marcescens to antibiotics.
    Begic S; Worobec EA
    Can J Microbiol; 2007 Jun; 53(6):710-9. PubMed ID: 17668031
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antibiogram and lipid analysis of a pigmented strain of Serratia marcescens and its nonpigmented variants.
    Button GL; Miller MA; Tsang JC
    Antimicrob Agents Chemother; 1975 Feb; 7(2):219-22. PubMed ID: 1094951
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization of spontaneous resistant variants of Serratia marcescens selected in the presence of carbenicillin.
    Platt DJ; Sommerville JS; McGroarty JA
    J Antimicrob Chemother; 1983 Oct; 12(4):329-35. PubMed ID: 6358176
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Urinary tract infections due to Serratia marcescens. I. Antimicrobial susceptibility patterns of clinical isolates of Serratia marcescens (author's transl)].
    Igari J; Kosakai N
    Jpn J Antibiot; 1977 Oct; 30(10):840-6. PubMed ID: 338940
    [No Abstract]   [Full Text] [Related]  

  • 50. Evidence of an efflux pump in Serratia marcescens.
    Berlanga M; Vázquez JL; Hernandez-Borrell J; Montero MT; Viñas M
    Microb Drug Resist; 2000; 6(2):111-7. PubMed ID: 10990265
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [O-serotypes, biochemical properties and antimicrobial susceptibilities of Serratia marcescens isolated from clinical specimens (2nd report)].
    Marumo K; Takeuchi T; Aoki Y
    Rinsho Byori; 1990 Sep; 38(9):1077-82. PubMed ID: 1700174
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antimicrobial susceptibility of Serratia marcescens isolated from clinical materials.
    Igari J; Oguri T; Kosakai N
    Jpn J Antibiot; 1984 Sep; 37(9):1625-30. PubMed ID: 6392599
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Infection with netilmicin resistant Serratia marcescens.
    Casewell MW; Ronan P
    Br Med J (Clin Res Ed); 1984 Feb; 288(6415):487. PubMed ID: 6419979
    [No Abstract]   [Full Text] [Related]  

  • 54. Serratia marcescens internalization and replication in human bladder epithelial cells.
    Hertle R; Schwarz H
    BMC Infect Dis; 2004 Jun; 4():16. PubMed ID: 15189566
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Umbelliprenin from Ferula persica roots inhibits the red pigment production in Serratia marcescens.
    Iranshahi M; Shahverdi AR; Mirjani R; Amin G; Shafiee A
    Z Naturforsch C J Biosci; 2004; 59(7-8):506-8. PubMed ID: 15813369
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sensitivity of hospital strains of Serratia marcescens to aminoglycosides.
    Vandepitte JM; Verbist L; Meeussen L
    Acta Clin Belg; 1976; 31(3):153-7. PubMed ID: 782126
    [No Abstract]   [Full Text] [Related]  

  • 57. [Antibmicrobial susceptibility of Serratia marcescens isolated from hospitalized patients in 2003 - 2005].
    Młynarczyk G; Młynarczyk A; Pupek J; Bilewska A; Luczak M
    Med Dosw Mikrobiol; 2007; 59(1):35-42. PubMed ID: 17601029
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serratia marcescens. Biochemical characteristics, antibiotic susceptibility patterns, and clinical significance.
    Wilkowske CJ; Washington JA; Martin WJ; Ritts RE
    JAMA; 1970 Dec; 214(12):2157-62. PubMed ID: 4320616
    [No Abstract]   [Full Text] [Related]  

  • 59. Outbreaks of Serratia marcescens bacteriuria in a neurosurgical intensive care unit of a tertiary care teaching hospital: a clinical, epidemiologic, and laboratory perspective.
    Yoon HJ; Choi JY; Park YS; Kim CO; Kim JM; Yong DE; Lee KW; Song YG
    Am J Infect Control; 2005 Dec; 33(10):595-601. PubMed ID: 16330308
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Detection of the plasmid-mediated quinolone resistance determinants in clinical isolates of Serratia marcescens in China.
    Yang HF; Cheng J; Hu LF; Ye Y; Li JB
    J Antibiot (Tokyo); 2012 Oct; 65(10):531-3. PubMed ID: 22854338
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.